Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherShort Communication

CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline

Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
Drug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
Tatsuki Fukami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miki Nakajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haruko Sakai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miki Katoh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuyoshi Yokoi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 35 no. 3 335-339
DOI 
https://doi.org/10.1124/dmd.106.011064
PubMed 
17178771

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 24, 2006
  • Accepted December 15, 2006
  • Published online February 26, 2007.

Article Versions

  • Earlier version (December 18, 2006 - 08:07).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Tatsuki Fukami,
  2. Miki Nakajima,
  3. Haruko Sakai,
  4. Miki Katoh and
  5. Tsuyoshi Yokoi
  1. Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
  1. Address correspondence to:
    Miki Nakajima, Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan. E-mail: nmiki{at}kenroku.kanazawa-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2006 to January 2021

AbstractFullPdf
Dec 200620040
Jan 2007200121
Feb 200725163
Mar 2007421419
Apr 2007211619
May 2007181316
Jun 2007132218
Jul 2007141214
Aug 200720710
Sep 20072747
Oct 20071733
Nov 200711810
Dec 20074514
Jan 2008898
Feb 20081213
Mar 200882520
Apr 2008122722
May 2008121815
Jun 2008132015
Jul 2008252531
Aug 2008212712
Sep 2008182715
Oct 2008142115
Nov 2008272315
Dec 20083108
Jan 200942221
Feb 200951410
Mar 2009112622
Apr 200981921
May 200941716
Jun 200971016
Jul 200971213
Aug 20096168
Sep 20091098
Oct 2009151913
Nov 2009131213
Dec 2009131010
Jan 2010231712
Feb 2010181310
Mar 2010181519
Apr 201011129
May 2010312112
Jun 20101585
Jul 201019911
Aug 201018107
Sep 2010131311
Oct 2010282630
Nov 2010202518
Dec 201017159
Jan 2011151014
Feb 201117713
Mar 2011121523
Apr 2011131213
May 2011151116
Jun 2011989
Jul 2011141417
Aug 201121816
Sep 2011181014
Oct 2011112310
Nov 2011152012
Dec 2011122912
Jan 2012151010
Feb 201281713
Mar 2012301812
Apr 2012181213
May 2012241211
Jun 2012171012
Jul 201213106
Aug 201219217
Sep 201217107
Oct 2012211737
Nov 2012142329
Dec 2012231111
Jan 2013201916
Feb 2013151416
Mar 2013192015
Apr 2013131817
May 2013241218
Jun 2013281611
Jul 201318133
Aug 2013151611
Sep 201319157
Oct 2013882
Nov 2013055
Dec 20135161
Jan 2014772
Feb 20141039
Mar 201410148
Apr 2014984
May 20141284
Jun 20148103
Jul 2014673
Aug 20146157
Sep 20141105
Oct 20141052
Nov 20145106
Dec 2014853
Jan 2015696
Feb 2015191
Mar 20157105
Apr 20157125
May 20156168
Jun 20154812
Jul 20151287
Aug 20155152
Sep 201528238
Oct 20153281
Nov 20151346
Dec 2015397
Jan 201681714
Feb 201610810
Mar 20166916
Apr 20163147
May 2016648
Jun 201691012
Jul 20163612
Aug 20165715
Sep 20164720
Oct 20165209
Nov 201611314
Dec 20162720
Jan 201702415
Feb 20170172
Mar 201701019
Apr 2017188
May 20174123
Jun 20174158
Jul 20170512
Aug 201731011
Sep 201732216
Oct 201723010
Nov 20176239
Dec 20172132
Jan 20184355
Feb 20186175
Mar 201832311
Apr 20185284
May 20180206
Jun 20182166
Jul 20180103
Aug 20180196
Sep 20180175
Oct 20180154
Nov 20180199
Dec 20181872
Jan 20192113
Feb 20191718
Mar 20191620
Apr 2019921
May 20191222
Jun 20191505
Jul 20191514
Aug 20192811
Sep 20193621
Oct 20192110
Nov 20193110
Dec 20192321
Jan 20202450
Feb 20201811
Mar 20201247
Apr 20201410
May 20201012
Jun 20201601
Jul 20201311
Aug 20202135
Sep 20202006
Oct 20201725
Nov 20202133
Dec 20202423
Jan 20211482

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 35 (3)
Drug Metabolism and Disposition
Vol. 35, Issue 3
1 Mar 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherShort Communication

CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline

Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
Drug Metabolism and Disposition March 1, 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OtherShort Communication

CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline

Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
Drug Metabolism and Disposition March 1, 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more SHORT COMMUNICATIONS

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics